GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » Beneish M-Score

China Health Industries Holdings (China Health Industries Holdings) Beneish M-Score : 42.08 (As of May. 11, 2024)


View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 42.08 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for China Health Industries Holdings's Beneish M-Score or its related term are showing as below:

CHHE' s Beneish M-Score Range Over the Past 10 Years
Min: -5.9   Med: -2.59   Max: 52.38
Current: 42.08

During the past 13 years, the highest Beneish M-Score of China Health Industries Holdings was 52.38. The lowest was -5.90. And the median was -2.59.


China Health Industries Holdings Beneish M-Score Historical Data

The historical data trend for China Health Industries Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings Beneish M-Score Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.68 -1.28 -3.28 - -

China Health Industries Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.09 0.36 - - 42.08

Competitive Comparison of China Health Industries Holdings's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's Beneish M-Score falls into.



China Health Industries Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of China Health Industries Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.0434+0.528 * -3.5455+0.404 * 9.7212+0.892 * 3.5455+0.115 * 1.3006
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.2904+4.679 * 9.684877-0.327 * 11.4706
=42.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.01 Mil.
Revenue was 0 + 0.038 + 0.058 + 0.021 = $0.12 Mil.
Gross Profit was 0 + 0 + -0.005 + 0.002 = $-0.00 Mil.
Total Current Assets was $0.25 Mil.
Total Assets was $4.27 Mil.
Property, Plant and Equipment(Net PPE) was $3.04 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.52 Mil.
Selling, General, & Admin. Expense(SGA) was $1.18 Mil.
Total Current Liabilities was $6.56 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -0.446 + -0.182 + -0.591 + -0.29 = $-1.51 Mil.
Non Operating Income was 0 + 0 + -0.008 + 0.012 = $0.00 Mil.
Cash Flow from Operations was 0 + -0.035 + -42.762 + -0.022 = $-42.82 Mil.
Total Receivables was $0.04 Mil.
Revenue was 0.033 + 0 + 0 + 0 = $0.03 Mil.
Gross Profit was 0.003 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $43.88 Mil.
Total Assets was $48.53 Mil.
Property, Plant and Equipment(Net PPE) was $3.52 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.82 Mil.
Selling, General, & Admin. Expense(SGA) was $1.15 Mil.
Total Current Liabilities was $6.50 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.006 / 0.117) / (0.039 / 0.033)
=0.051282 / 1.181818
=0.0434

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.003 / 0.033) / (-0.003 / 0.117)
=0.090909 / -0.025641
=-3.5455

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.249 + 3.043) / 4.265) / (1 - (43.875 + 3.52) / 48.534)
=0.228136 / 0.023468
=9.7212

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.117 / 0.033
=3.5455

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.818 / (0.818 + 3.52)) / (0.516 / (0.516 + 3.043))
=0.188566 / 0.144985
=1.3006

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.179 / 0.117) / (1.145 / 0.033)
=10.076923 / 34.69697
=0.2904

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 6.555) / 4.265) / ((0 + 6.503) / 48.534)
=1.536928 / 0.133989
=11.4706

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1.509 - 0.004 - -42.819) / 4.265
=9.684877

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

China Health Industries Holdings has a M-score of 42.08 signals that the company is likely to be a manipulator.


China Health Industries Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Industries Holdings (China Health Industries Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
Sun Xin director, 10 percent owner, officer: CEO, CFO and Treasurer NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing director, officer: Secretary 2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson director 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster director 402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn director, officer: COO 422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee 10 percent owner 3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems 10 percent owner, officer: President, CEO, CFO and, other: Secretary 1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines